Drugs and devices already on the market await FDA-ordered studies
Records indicate that many postmarket studies required by the FDA for drugs and medical devices are currently overdue or behind schedule.
To get drugs and devices out faster, the FDA lets companies conduct studies after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.
READ NEXT
More on the wire
AI TLDR
Readers of the Inquirer shared their perspectives on the midterm elections and a recent local referendum in a South Jersey town that was decided by nine votes.
AI TLDR
Blues musician Buddy Guy was honored with a sold-out concert at Radio City Music Hall shortly after his 90th birthday.
AI TLDR
Bryce Harper addressed the Philadelphia Phillies' early playoff exit, stating the team failed to achieve its goal of winning games.